nodes	percent_of_prediction	percent_of_DWPC	metapath
Medroxyprogesterone Acetate—CYP2C8—Rifampicin—leprosy	0.15	0.219	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Dapsone—leprosy	0.124	0.181	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Thalidomide—leprosy	0.108	0.158	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Rifampicin—leprosy	0.104	0.153	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Dapsone—leprosy	0.0862	0.126	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Rifampicin—leprosy	0.0608	0.089	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Dapsone—leprosy	0.0501	0.0734	CbGbCtD
Medroxyprogesterone Acetate—AR—scrotum—leprosy	0.0167	0.295	CbGeAlD
Medroxyprogesterone Acetate—Hodgkin's disease lymphocyte predominance type stage unspecified—Thalidomide—leprosy	0.0149	0.0572	CcSEcCtD
Medroxyprogesterone Acetate—Hodgkin's disease—Thalidomide—leprosy	0.0149	0.0572	CcSEcCtD
Medroxyprogesterone Acetate—Hodgkin's disease lymphocyte depletion type stage unspecified—Thalidomide—leprosy	0.0149	0.0572	CcSEcCtD
Medroxyprogesterone Acetate—Cholangitis—Thalidomide—leprosy	0.00809	0.0311	CcSEcCtD
Medroxyprogesterone Acetate—SHBG—hindlimb—leprosy	0.00794	0.14	CbGeAlD
Medroxyprogesterone Acetate—Nephrotic syndrome—Dapsone—leprosy	0.00567	0.0218	CcSEcCtD
Medroxyprogesterone Acetate—Thromboembolic event—Thalidomide—leprosy	0.00521	0.02	CcSEcCtD
Medroxyprogesterone Acetate—Arterial thrombosis—Thalidomide—leprosy	0.00521	0.02	CcSEcCtD
Medroxyprogesterone Acetate—Acute leukaemia—Thalidomide—leprosy	0.00491	0.0189	CcSEcCtD
Medroxyprogesterone Acetate—Thromboembolism—Thalidomide—leprosy	0.00441	0.017	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—testis—leprosy	0.00349	0.0615	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—nervous system—leprosy	0.00342	0.0604	CbGeAlD
Medroxyprogesterone Acetate—PGR—blood vessel—leprosy	0.00341	0.0602	CbGeAlD
Medroxyprogesterone Acetate—Erythema nodosum—Thalidomide—leprosy	0.00325	0.0125	CcSEcCtD
Medroxyprogesterone Acetate—Pericarditis—Thalidomide—leprosy	0.00325	0.0125	CcSEcCtD
Medroxyprogesterone Acetate—Proteinuria—Dapsone—leprosy	0.00312	0.012	CcSEcCtD
Medroxyprogesterone Acetate—Parkinsonism—Thalidomide—leprosy	0.00309	0.0119	CcSEcCtD
Medroxyprogesterone Acetate—Protein urine present—Dapsone—leprosy	0.00308	0.0118	CcSEcCtD
Medroxyprogesterone Acetate—Cerebral ischaemia—Thalidomide—leprosy	0.0029	0.0112	CcSEcCtD
Medroxyprogesterone Acetate—Transient ischaemic attack—Thalidomide—leprosy	0.00278	0.0107	CcSEcCtD
Medroxyprogesterone Acetate—Embolism venous—Thalidomide—leprosy	0.00278	0.0107	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—blood vessel—leprosy	0.00267	0.0471	CbGeAlD
Medroxyprogesterone Acetate—Venous thrombosis—Thalidomide—leprosy	0.0026	0.00999	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—nerve—leprosy	0.00251	0.0443	CbGeAlD
Medroxyprogesterone Acetate—Foetor hepaticus—Thalidomide—leprosy	0.00247	0.0095	CcSEcCtD
Medroxyprogesterone Acetate—Deep vein thrombosis—Thalidomide—leprosy	0.00231	0.00886	CcSEcCtD
Medroxyprogesterone Acetate—Embolism—Thalidomide—leprosy	0.00219	0.0084	CcSEcCtD
Medroxyprogesterone Acetate—Hypothyroidism—Thalidomide—leprosy	0.00219	0.0084	CcSEcCtD
Medroxyprogesterone Acetate—Galactorrhoea—Thalidomide—leprosy	0.00216	0.00831	CcSEcCtD
Medroxyprogesterone Acetate—Liver disorder—Thalidomide—leprosy	0.00206	0.00791	CcSEcCtD
Medroxyprogesterone Acetate—Hypercalcaemia—Thalidomide—leprosy	0.00202	0.00776	CcSEcCtD
Medroxyprogesterone Acetate—Hepatomegaly—Thalidomide—leprosy	0.00198	0.00762	CcSEcCtD
Medroxyprogesterone Acetate—Thrombosis—Thalidomide—leprosy	0.00198	0.00762	CcSEcCtD
Medroxyprogesterone Acetate—Metrorrhagia—Thalidomide—leprosy	0.00197	0.00755	CcSEcCtD
Medroxyprogesterone Acetate—Psychotic disorder—Dapsone—leprosy	0.00194	0.00747	CcSEcCtD
Medroxyprogesterone Acetate—Neuritis—Thalidomide—leprosy	0.00188	0.00722	CcSEcCtD
Medroxyprogesterone Acetate—Nasopharyngitis—Dapsone—leprosy	0.00178	0.00684	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—tendon—leprosy	0.00178	0.0313	CbGeAlD
Medroxyprogesterone Acetate—Muscular weakness—Dapsone—leprosy	0.00176	0.00674	CcSEcCtD
Medroxyprogesterone Acetate—Influenza—Dapsone—leprosy	0.00172	0.00661	CcSEcCtD
Medroxyprogesterone Acetate—Endocrine disorder—Thalidomide—leprosy	0.00169	0.0065	CcSEcCtD
Medroxyprogesterone Acetate—Blood disorder—Thalidomide—leprosy	0.00168	0.00646	CcSEcCtD
Medroxyprogesterone Acetate—Acne—Thalidomide—leprosy	0.00167	0.00641	CcSEcCtD
Medroxyprogesterone Acetate—Amenorrhoea—Thalidomide—leprosy	0.0016	0.00614	CcSEcCtD
Medroxyprogesterone Acetate—Jaundice cholestatic—Thalidomide—leprosy	0.0016	0.00614	CcSEcCtD
Medroxyprogesterone Acetate—Proteinuria—Thalidomide—leprosy	0.0016	0.00614	CcSEcCtD
Medroxyprogesterone Acetate—Protein urine present—Thalidomide—leprosy	0.00158	0.00605	CcSEcCtD
Medroxyprogesterone Acetate—Bone disorder—Thalidomide—leprosy	0.00155	0.00597	CcSEcCtD
Medroxyprogesterone Acetate—Drug interaction—Thalidomide—leprosy	0.00151	0.00581	CcSEcCtD
Medroxyprogesterone Acetate—Neuropathy peripheral—Dapsone—leprosy	0.0015	0.00578	CcSEcCtD
Medroxyprogesterone Acetate—Leukocytosis—Thalidomide—leprosy	0.00149	0.00574	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—testis—leprosy	0.00147	0.026	CbGeAlD
Medroxyprogesterone Acetate—Sinusitis—Dapsone—leprosy	0.00144	0.00553	CcSEcCtD
Medroxyprogesterone Acetate—Hepatocellular injury—Thalidomide—leprosy	0.0014	0.00539	CcSEcCtD
Medroxyprogesterone Acetate—Phosphatase alkaline increased—Thalidomide—leprosy	0.0014	0.00539	CcSEcCtD
Medroxyprogesterone Acetate—Pulmonary embolism—Thalidomide—leprosy	0.0014	0.00539	CcSEcCtD
Medroxyprogesterone Acetate—Hyperkalaemia—Thalidomide—leprosy	0.00138	0.0053	CcSEcCtD
Medroxyprogesterone Acetate—Pharyngitis—Dapsone—leprosy	0.00137	0.00525	CcSEcCtD
Medroxyprogesterone Acetate—Cramps of lower extremities—Thalidomide—leprosy	0.00129	0.00495	CcSEcCtD
Medroxyprogesterone Acetate—Tinnitus—Dapsone—leprosy	0.00128	0.00493	CcSEcCtD
Medroxyprogesterone Acetate—AR—skin of body—leprosy	0.00126	0.0222	CbGeAlD
Medroxyprogesterone Acetate—Sepsis—Thalidomide—leprosy	0.00122	0.00468	CcSEcCtD
Medroxyprogesterone Acetate—Euphoric mood—Thalidomide—leprosy	0.00121	0.00463	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Dapsone—leprosy	0.0012	0.0046	CcSEcCtD
Medroxyprogesterone Acetate—Thrombophlebitis—Thalidomide—leprosy	0.00118	0.00452	CcSEcCtD
Medroxyprogesterone Acetate—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.00117	0.0045	CcSEcCtD
Medroxyprogesterone Acetate—Diabetes mellitus—Thalidomide—leprosy	0.00117	0.0045	CcSEcCtD
Medroxyprogesterone Acetate—Cardiac failure congestive—Thalidomide—leprosy	0.00112	0.00432	CcSEcCtD
Medroxyprogesterone Acetate—SHBG—testis—leprosy	0.00111	0.0195	CbGeAlD
Medroxyprogesterone Acetate—Libido decreased—Thalidomide—leprosy	0.0011	0.00422	CcSEcCtD
Medroxyprogesterone Acetate—Amnesia—Thalidomide—leprosy	0.00108	0.00417	CcSEcCtD
Medroxyprogesterone Acetate—Increased appetite—Thalidomide—leprosy	0.00108	0.00417	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Dapsone—leprosy	0.00108	0.00414	CcSEcCtD
Medroxyprogesterone Acetate—Visual disturbance—Thalidomide—leprosy	0.00108	0.00413	CcSEcCtD
Medroxyprogesterone Acetate—Purpura—Thalidomide—leprosy	0.00106	0.00406	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—eye—leprosy	0.00105	0.0185	CbGeAlD
Medroxyprogesterone Acetate—Hypoglycaemia—Thalidomide—leprosy	0.00104	0.00401	CcSEcCtD
Medroxyprogesterone Acetate—Cerebrovascular accident—Thalidomide—leprosy	0.00104	0.00399	CcSEcCtD
Medroxyprogesterone Acetate—Osteoarthritis—Thalidomide—leprosy	0.00102	0.00391	CcSEcCtD
Medroxyprogesterone Acetate—Pain in extremity—Thalidomide—leprosy	0.00102	0.00391	CcSEcCtD
Medroxyprogesterone Acetate—Disturbance in sexual arousal—Thalidomide—leprosy	0.00101	0.00388	CcSEcCtD
Medroxyprogesterone Acetate—Migraine—Thalidomide—leprosy	0.001	0.00385	CcSEcCtD
Medroxyprogesterone Acetate—Affect lability—Thalidomide—leprosy	0.001	0.00385	CcSEcCtD
Medroxyprogesterone Acetate—PGR—testis—leprosy	0.000996	0.0176	CbGeAlD
Medroxyprogesterone Acetate—Psychotic disorder—Thalidomide—leprosy	0.000995	0.00382	CcSEcCtD
Medroxyprogesterone Acetate—Face oedema—Thalidomide—leprosy	0.000984	0.00378	CcSEcCtD
Medroxyprogesterone Acetate—PGR—nervous system—leprosy	0.000978	0.0172	CbGeAlD
Medroxyprogesterone Acetate—Mood swings—Thalidomide—leprosy	0.000965	0.00371	CcSEcCtD
Medroxyprogesterone Acetate—AR—tendon—leprosy	0.000959	0.0169	CbGeAlD
Medroxyprogesterone Acetate—Ataxia—Thalidomide—leprosy	0.000958	0.00368	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Dapsone—leprosy	0.000955	0.00367	CcSEcCtD
Medroxyprogesterone Acetate—Blood creatinine increased—Thalidomide—leprosy	0.000955	0.00367	CcSEcCtD
Medroxyprogesterone Acetate—Dry skin—Thalidomide—leprosy	0.000934	0.00359	CcSEcCtD
Medroxyprogesterone Acetate—Orthostatic hypotension—Thalidomide—leprosy	0.000931	0.00358	CcSEcCtD
Medroxyprogesterone Acetate—Hypokalaemia—Thalidomide—leprosy	0.000927	0.00356	CcSEcCtD
Medroxyprogesterone Acetate—Breast disorder—Thalidomide—leprosy	0.000921	0.00354	CcSEcCtD
Medroxyprogesterone Acetate—Cramp muscle—Thalidomide—leprosy	0.000918	0.00352	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—skin of body—leprosy	0.000912	0.0161	CbGeAlD
Medroxyprogesterone Acetate—Alanine aminotransferase increased—Thalidomide—leprosy	0.000899	0.00345	CcSEcCtD
Medroxyprogesterone Acetate—Muscular weakness—Thalidomide—leprosy	0.000899	0.00345	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal distension—Thalidomide—leprosy	0.000887	0.00341	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Dapsone—leprosy	0.000885	0.0034	CcSEcCtD
Medroxyprogesterone Acetate—Dysphagia—Thalidomide—leprosy	0.000881	0.00338	CcSEcCtD
Medroxyprogesterone Acetate—Influenza—Thalidomide—leprosy	0.000881	0.00338	CcSEcCtD
Medroxyprogesterone Acetate—Bronchospasm—Thalidomide—leprosy	0.000866	0.00333	CcSEcCtD
Medroxyprogesterone Acetate—Bronchitis—Thalidomide—leprosy	0.000847	0.00325	CcSEcCtD
Medroxyprogesterone Acetate—Upper respiratory tract infection—Thalidomide—leprosy	0.000819	0.00314	CcSEcCtD
Medroxyprogesterone Acetate—Pollakiuria—Thalidomide—leprosy	0.000814	0.00313	CcSEcCtD
Medroxyprogesterone Acetate—Weight increased—Thalidomide—leprosy	0.000802	0.00308	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Dapsone—leprosy	0.0008	0.00307	CcSEcCtD
Medroxyprogesterone Acetate—Weight decreased—Thalidomide—leprosy	0.000797	0.00306	CcSEcCtD
Medroxyprogesterone Acetate—Hyperglycaemia—Thalidomide—leprosy	0.000794	0.00305	CcSEcCtD
Medroxyprogesterone Acetate—AR—testis—leprosy	0.000794	0.014	CbGeAlD
Medroxyprogesterone Acetate—Drowsiness—Thalidomide—leprosy	0.000785	0.00302	CcSEcCtD
Medroxyprogesterone Acetate—Infestation NOS—Thalidomide—leprosy	0.000785	0.00302	CcSEcCtD
Medroxyprogesterone Acetate—Infestation—Thalidomide—leprosy	0.000785	0.00302	CcSEcCtD
Medroxyprogesterone Acetate—Depression—Thalidomide—leprosy	0.000783	0.00301	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—testis—leprosy	0.000779	0.0137	CbGeAlD
Medroxyprogesterone Acetate—AR—nervous system—leprosy	0.000779	0.0137	CbGeAlD
Medroxyprogesterone Acetate—Acute coronary syndrome—Thalidomide—leprosy	0.000774	0.00297	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Dapsone—leprosy	0.000773	0.00297	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Dapsone—leprosy	0.000773	0.00297	CcSEcCtD
Medroxyprogesterone Acetate—Neuropathy peripheral—Thalidomide—leprosy	0.00077	0.00296	CcSEcCtD
Medroxyprogesterone Acetate—Myocardial infarction—Thalidomide—leprosy	0.00077	0.00296	CcSEcCtD
Medroxyprogesterone Acetate—Stomatitis—Thalidomide—leprosy	0.000765	0.00294	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—nervous system—leprosy	0.000765	0.0135	CbGeAlD
Medroxyprogesterone Acetate—Sweating—Thalidomide—leprosy	0.000753	0.00289	CcSEcCtD
Medroxyprogesterone Acetate—Epistaxis—Thalidomide—leprosy	0.000741	0.00285	CcSEcCtD
Medroxyprogesterone Acetate—Sinusitis—Thalidomide—leprosy	0.000737	0.00283	CcSEcCtD
Medroxyprogesterone Acetate—Bradycardia—Thalidomide—leprosy	0.000718	0.00276	CcSEcCtD
Medroxyprogesterone Acetate—Hepatitis—Thalidomide—leprosy	0.000705	0.00271	CcSEcCtD
Medroxyprogesterone Acetate—Pharyngitis—Thalidomide—leprosy	0.0007	0.00269	CcSEcCtD
Medroxyprogesterone Acetate—Urinary tract disorder—Thalidomide—leprosy	0.000696	0.00267	CcSEcCtD
Medroxyprogesterone Acetate—Oedema peripheral—Thalidomide—leprosy	0.000694	0.00267	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—tendon—leprosy	0.000694	0.0122	CbGeAlD
Medroxyprogesterone Acetate—Urethral disorder—Thalidomide—leprosy	0.000691	0.00265	CcSEcCtD
Medroxyprogesterone Acetate—Visual impairment—Thalidomide—leprosy	0.000679	0.00261	CcSEcCtD
Medroxyprogesterone Acetate—Erythema multiforme—Thalidomide—leprosy	0.000667	0.00256	CcSEcCtD
Medroxyprogesterone Acetate—Eye disorder—Thalidomide—leprosy	0.000659	0.00253	CcSEcCtD
Medroxyprogesterone Acetate—Tinnitus—Thalidomide—leprosy	0.000657	0.00252	CcSEcCtD
Medroxyprogesterone Acetate—Cardiac disorder—Thalidomide—leprosy	0.000654	0.00251	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C8—testis—leprosy	0.000642	0.0113	CbGeAlD
Medroxyprogesterone Acetate—Angiopathy—Thalidomide—leprosy	0.00064	0.00246	CcSEcCtD
Medroxyprogesterone Acetate—Immune system disorder—Thalidomide—leprosy	0.000637	0.00245	CcSEcCtD
Medroxyprogesterone Acetate—Mediastinal disorder—Thalidomide—leprosy	0.000635	0.00244	CcSEcCtD
Medroxyprogesterone Acetate—Chills—Thalidomide—leprosy	0.000633	0.00243	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Thalidomide—leprosy	0.000623	0.00239	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Dapsone—leprosy	0.000622	0.00239	CcSEcCtD
Medroxyprogesterone Acetate—Mental disorder—Thalidomide—leprosy	0.000618	0.00237	CcSEcCtD
Medroxyprogesterone Acetate—Malnutrition—Thalidomide—leprosy	0.000614	0.00236	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Dapsone—leprosy	0.000613	0.00235	CcSEcCtD
Medroxyprogesterone Acetate—Flatulence—Thalidomide—leprosy	0.000605	0.00232	CcSEcCtD
Medroxyprogesterone Acetate—Tension—Thalidomide—leprosy	0.000602	0.00231	CcSEcCtD
Medroxyprogesterone Acetate—Dysgeusia—Thalidomide—leprosy	0.000601	0.00231	CcSEcCtD
Medroxyprogesterone Acetate—Nervousness—Thalidomide—leprosy	0.000596	0.00229	CcSEcCtD
Medroxyprogesterone Acetate—Back pain—Thalidomide—leprosy	0.000594	0.00228	CcSEcCtD
Medroxyprogesterone Acetate—Muscle spasms—Thalidomide—leprosy	0.00059	0.00227	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Dapsone—leprosy	0.000581	0.00223	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—testis—leprosy	0.000575	0.0101	CbGeAlD
Medroxyprogesterone Acetate—Tremor—Thalidomide—leprosy	0.000575	0.00221	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Thalidomide—leprosy	0.000569	0.00219	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Thalidomide—leprosy	0.000567	0.00218	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—nervous system—leprosy	0.000564	0.00995	CbGeAlD
Medroxyprogesterone Acetate—Agitation—Thalidomide—leprosy	0.000564	0.00217	CcSEcCtD
Medroxyprogesterone Acetate—Angioedema—Thalidomide—leprosy	0.000561	0.00215	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Thalidomide—leprosy	0.000553	0.00213	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Thalidomide—leprosy	0.000551	0.00212	CcSEcCtD
Medroxyprogesterone Acetate—Syncope—Thalidomide—leprosy	0.00055	0.00211	CcSEcCtD
Medroxyprogesterone Acetate—Palpitations—Thalidomide—leprosy	0.000542	0.00208	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Thalidomide—leprosy	0.000539	0.00207	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Thalidomide—leprosy	0.000532	0.00204	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Thalidomide—leprosy	0.000522	0.00201	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Thalidomide—leprosy	0.000522	0.00201	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Thalidomide—leprosy	0.000522	0.00201	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Thalidomide—leprosy	0.000521	0.002	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000519	0.00199	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Thalidomide—leprosy	0.000516	0.00198	CcSEcCtD
Medroxyprogesterone Acetate—Dry mouth—Thalidomide—leprosy	0.000511	0.00196	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Thalidomide—leprosy	0.000505	0.00194	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Thalidomide—leprosy	0.000501	0.00192	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Thalidomide—leprosy	0.000498	0.00191	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Thalidomide—leprosy	0.000493	0.00189	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Thalidomide—leprosy	0.000491	0.00189	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Thalidomide—leprosy	0.00049	0.00188	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Thalidomide—leprosy	0.000489	0.00188	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Thalidomide—leprosy	0.000486	0.00187	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Thalidomide—leprosy	0.000484	0.00186	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Thalidomide—leprosy	0.000477	0.00183	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Thalidomide—leprosy	0.000468	0.0018	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Thalidomide—leprosy	0.000456	0.00175	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Thalidomide—leprosy	0.000453	0.00174	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Thalidomide—leprosy	0.00045	0.00173	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Thalidomide—leprosy	0.000447	0.00172	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Thalidomide—leprosy	0.000445	0.00171	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Thalidomide—leprosy	0.000441	0.00169	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Thalidomide—leprosy	0.000435	0.00167	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Thalidomide—leprosy	0.000432	0.00166	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Thalidomide—leprosy	0.000432	0.00166	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Thalidomide—leprosy	0.000428	0.00165	CcSEcCtD
Medroxyprogesterone Acetate—CYP3A4—nervous system—leprosy	0.000427	0.00753	CbGeAlD
Medroxyprogesterone Acetate—Feeling abnormal—Thalidomide—leprosy	0.000413	0.00159	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Thalidomide—leprosy	0.00041	0.00157	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Thalidomide—leprosy	0.000398	0.00153	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Thalidomide—leprosy	0.000396	0.00152	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Thalidomide—leprosy	0.000396	0.00152	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Thalidomide—leprosy	0.000369	0.00142	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Thalidomide—leprosy	0.000359	0.00138	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Thalidomide—leprosy	0.000354	0.00136	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Thalidomide—leprosy	0.000343	0.00132	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Thalidomide—leprosy	0.000331	0.00127	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Thalidomide—leprosy	0.000318	0.00122	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Thalidomide—leprosy	0.000316	0.00121	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Thalidomide—leprosy	0.000316	0.00121	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Thalidomide—leprosy	0.000314	0.00121	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Thalidomide—leprosy	0.000298	0.00114	CcSEcCtD
